B-LCL-CDG2 Cells - Rare diseases - cell lines
Produktgrößen
1 each
£1065,00
302013-1EACH
Über dieses Produkt
- SKU:
- 302013
- Anwendung:
- Apoptosis, Cell-based/Functional Assay
- CE/IVD:
- Our cells are provided for in vitro laboratory research purposes exclusively and are not intended fo
- Weitere Details:
- B-LCL-CDG2 is an EBV-transformed B lymphocyte cell line derived from a young girl suffering from PMM2-CDG. PMM2-CDG is a rare inborn error of metabolism, which results in defective synthesis of glycosylated oligosaccharide chains of many tissue and blood glycoproteins and/or glycosphingolipids. The primary cause of defective glycosylation is based on mutations in the enzyme phosphomannomutase 2 (PMM2). There are two distinct mutations for the PMM2 gene.
- Versandbedingungen:
- Dry Ice
- Lagerbedingungen:
- Liquid N2, -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Cytion
- Typ:
- Cells: Cell Lines
- Datenblatt des Herstellers:89b5764541fd4c7b9c8c46de098bde09